For years, congressional Democrats have tried to pass legislation to allow Medicare to negotiate prescription drug prices for millions of beneficiaries. Now, they believe they have a not-so-secret weapon: President Donald Trump.

Continue reading

In this year’s presidential campaign, health care has taken a back seat. But one issue appears to be breaking through: the rising cost of prescription drugs.

Continue reading

Identical to the original product -- a pre-filled syringe containing epinephrine, used for life-threatening allergic reactions -- the generic will cost $300 for two.

Continue reading

Medicare announced a test program last week to help combat this rising drug prices.

Continue reading

The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.

Continue reading

In our news wrap Thursday, embattled ex-Turing Pharmaceuticals CEO Martin Shkreli pleaded the Fifth when called to testify before Congress on drug pricing protocols. Also, 12.7 million Americans signed up for private health insurance under the Affordable Care Act this…

Continue watching

In the 1980s, a law was passed to persuade pharmaceutical companies to develop drugs for small populations, but now that rule is being used to reclaim old "orphaned" drugs in order to raise prices and profits. Gwen Ifill learns more…

Continue watching

As more expensive specialty drugs come on the market to treat some of the most serious chronic diseases, more states are stepping in to cushion the financial pain for patients who need medicine that can cost up to hundreds of…

Continue reading